SS
NTLA icon

Sunbelt Securities’s Intellia Therapeutics NTLA Stock Holding History

Sunbelt Securities’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-570
Closed -$12.8K – 1888
2024
Q2 		$12.8K Hold
570
– – ﹤0.01% 1216
2024
Q1 		$15.7K Sell
570
-10
-2% -$278 ﹤0.01% 1140
2023
Q4 		$17.7K Sell
580
-40
-6% -$1.15K ﹤0.01% 1056
2023
Q3 		$19.6K Buy
620
+20
+3% +$776 ﹤0.01% 1020
2023
Q2 		$24.5K Hold
600
– – ﹤0.01% 971
2023
Q1 		$21.6K Buy
+600
New +$23.5K ﹤0.01% 939

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sunbelt Securities's NTLA Position: Q3 2024 in Review

Sunbelt Securities sold out of Intellia Therapeutics (NTLA) in Q3 2024, closing a stake of 570 shares — an estimated $12.8K sold.

Sunbelt Securities first reported a position in NTLA in Q1 2023 and held it in 6 quarters. The position peaked at $24.5K in Q2 2023. 283 funds tracked by Wall St. Rank hold NTLA as of Q3 2024.

  • Sunbelt Securities reported no remaining Intellia Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Sunbelt Securities sold 570 Intellia Therapeutics shares in Q3 2024, an estimated $12.8K.
  • Sunbelt Securities first reported a position in Intellia Therapeutics in Q1 2023 and held it in 6 quarters.
  • Sunbelt Securities's Intellia Therapeutics position peaked at $24.5K in Q2 2023.
  • 283 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2024.

Based on Sunbelt Securities's 13F filing for Q3 2024, filed 18 Nov 2024.